The development was announced in a statement issued on Wednesday by the National AIDS, Viral Hepatitis and STIs Control ...

SCIENTISTS have discovered a protein that is “indispensable” for malaria parasite survival, making it a potential target for antimalarial drugs. Aurora-related kinase 1 (ARK1) is a specialised protein ...

Pharmacologist, physician, and researcher who transformed malaria treatment. Born in London, UK, on March 13, 1951, he died of cancer in Oxford, UK, on Feb 1, 2026, aged 74 years.

Malaria is caused by a parasite that is spread to humans by infected mosquitoes. In 2024, almost 282 million people worldwide were infected and 610,000 died, according to the World Health Organization ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that three ...

Scientists have identified a unique protein, ARK1, which is essential for the malaria parasite's survival and transmission, offering a promising new target for antimalaria drugs.

Malaria killed about 610,000 people globally in 2024, with most deaths occurring in Africa, where young children remain the most vulnerable.

The study reveals that ARK1 controls spindle formation during malaria parasite division. Blocking this protein disrupted ...

Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a ...

Associate Professor of Chemistry at Obafemi Awolowo University (OAU), Ile-Ife, Olatomide Fadare, has dedicated his career to ...

The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...

Explore the latest breakthrough in malaria drugs targeting a unique protein essential for the parasite's survival and transmission.